Wedbush Securities’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,000
| Closed | -$132K | – | 1181 |
|
|
2024
Q4 | $132K | Hold |
10,000
| – | – | ﹤0.01% | 1069 |
|
|
2024
Q3 | $193K | Hold |
10,000
| – | – | 0.01% | 1006 |
|
|
2024
Q2 | $205K | Hold |
10,000
| – | – | 0.01% | 1070 |
|
|
2024
Q1 | $238K | Hold |
10,000
| – | – | 0.01% | 997 |
|
|
2023
Q4 | $216K | Hold |
10,000
| – | – | 0.01% | 926 |
|
|
2023
Q3 | $145K | Hold |
10,000
| – | – | 0.01% | 964 |
|
|
2023
Q2 | $209K | Hold |
10,000
| – | – | 0.01% | 916 |
|
|
2023
Q1 | $211K | Hold |
10,000
| – | – | 0.01% | 917 |
|
|
2022
Q4 | $255K | Hold |
10,000
| – | – | 0.01% | 800 |
|
|
2022
Q3 | $240K | Hold |
10,000
| – | – | 0.01% | 815 |
|
|
2022
Q2 | $192K | Hold |
10,000
| – | – | 0.01% | 937 |
|
|
2022
Q1 | $174K | Hold |
10,000
| – | – | 0.01% | 1008 |
|
|
2021
Q4 | $219K | Hold |
10,000
| – | – | 0.01% | 1025 |
|
|
2021
Q3 | $191K | Hold |
10,000
| – | – | 0.01% | 1076 |
|
|
2021
Q2 | $172K | Hold |
10,000
| – | – | 0.01% | 1082 |
|
|
2021
Q1 | $224K | Buy |
+10,000
| New | +$224K | 0.01% | 938 |
|